In univariate analysis, patients who relapsed more than six months after diagnosis (group R) showed a trend toward improved survival, although the evidence was not strong (β median 0.84; 90% CI: −0.01 to 1.79; ROPE 0.042; PD 0.948).
← all excerpts
Molecular Landscape of Advanced Endometrial Cancer: Exploratory Analyses at Modena Cancer Center (MEMO).
1
—
—